FineTest
SKU:EH1736
Human BAD(Bcl2 antagonist of cell death) ELISA Kit
Human BAD(Bcl2 antagonist of cell death) ELISA Kit
Couldn't load pickup availability
For research focused on BAD, the Bcl-2 antagonist of cell death, our Human BAD ELISA Kit (EH1736) is tailor-made to provide accurate and reliable measurements of BAD levels in human samples. Its salient attributes encompass:
Precision: The EH1736 kit offers highly precise quantification of BAD, reinforcing the integrity and trustworthiness of your research findings.
Broad Range: Its broad detection range accommodates a wide spectrum of sample concentrations, catering to diverse experimental requirements.
User-Friendly: The kit simplifies the experimental process through intuitive protocols, promoting ease of use.
Efficiency: Designed for efficiency, it minimizes laboratory work time, producing rapid results and elevating research productivity.
Product Name
Human BAD(Bcl2 antagonist of cell death) ELISA Kit
Alias
BAD ELISA Kit, Bcl2 antagonist of cell death ELISA Kit, Bcl-XL ELISA Kit, Bcl-2-associated death promoter ELISA Kit, Bcl-2-binding component 6 ELISA Kit, Bcl-2-like protein 8 ELISA Kit, Bcl2-L-8 ELISA Kit, Bcl2 Associated Death Promoter ELISA Kit, BBC2 ELISA Kit, BCL2L8 ELISA Kit
Detection Method
Sandwich ELISA, Double Antibody
Application
BAD ELISA Kit allows for the in vitro quantitative determination of BAD concentrations in serum, plasma, tissue homogenates and other biological fluids.
Size
96T
Range
0.156-10ng/ml
Sensitivity
< 0.094ng/ml
Species
Human
UniProt ID
Standard Curve

Storage
2-8 ℃ for 6 months
Recovery
Matrices listed below were spiked with certain level of BAD and the recovery rates were calculated by comparing the measured value to the expected amount of BAD in samples.
|
Matrix |
Recovery range(%) |
Average(%) |
|
serum(n=5) |
90-102 |
96 |
|
EDTA plasma(n=5) |
91-104 |
99 |
|
heparin plasma(n=5) |
86-105 |
98 |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of BAD and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
|
Sample |
1:2 |
1:4 |
1:8 |
|
serum(n=5) |
85-103% |
87-105% |
92-105% |
|
EDTA plasma(n=5) |
87-100% |
86-99% |
84-98% |
|
heparin plasma(n=5) |
82-95% |
81-100% |
85-98% |
CV(%)
Intra-Assay: CV<8%
Inter-Assay: CV<10%
Note
For Research Use Only
Share
